TG Therapeutics | Resultado Líquido



Net Income Alterar Data
AbbVie USD -22000000 1.58B 2024-12
Alaunos Therapeutics USD -1127000 2K 2024-09
Amgen USD 627M 2.2B 2024-12
Ardelyx USD 4.64M 5.45M 2024-12
Arrowhead Research USD -173085000 2.55M 2024-12
Bayer EUR -335000000 3.85B 2024-12
Biogen USD 266.7M 121.8M 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Dynavax Technologies USD 7.05M 10.54M 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
J&J USD 3.43B 737M 2024-12
Novartis USD 2.82B 371M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
TG Therapeutics USD 23.33M 19.45M 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



TG Therapeutics Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.